Myung-Whun Sung

Myung-Whun Sung

Auto-generated profile, based on publicly available information

Myung-Whun Sung

Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
DLDoh Young Lee
Doh Young Lee
JHJ. Hun Hah
J. Hun Hah
WJWoo-Jin Jeong
Woo-Jin Jeong
ECEun-Jae Chung
Eun-Jae Chung
TKTack-Kyun Kwon
Tack-Kyun Kwon
SKSeong Keun Kwon
Seong Keun Kwon
Objectives. We aimed to assess the genetic differences between cases of early-stage tongue cancer that were positive or negative for lymph node metastasis.Methods. In total, 35 cases of tongue cancer with RNA sequencing data were enrolled in this study. The gene expression profile of the following two groups was compared: N0 group (T stage 1 or 2 with N0 stage) and N+ group (T stage 1 or 2 with N+ stage). Using the R and limma packages in the Bioconductor program, we extracted the differentially expressed genes (DEGs). Gene ontology and pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integration Discovery (DAVID) online tool. Immune cell infiltration was analyzed using the CIBERSORT online program. Immunochemical staining of the cancer tissue was evaluated and The Cancer Genome Atlas (TCGA) data were analyzed to validate the identified DEGs.Results. No significant differences were found in the infiltration of 22 types of immune cells. Among a total of 51 identified DEGs, 14 genes were significantly upregulated, while 37 genes were significantly downregulated (P2). Pathway analysis revealed significant associations with the arachidonic acid metabolism-related pathway, calcium signaling, and the muscle contraction pathway. The following DEGs were the most significantly different between the two groups: DEFB4A, SPRR2B, DEFB103B, SPRR2G, DEFB4B, and FAM25A. TCGA data showed that DEFB4A and DEFB103B were more highly expressed in the N0 group than in the N+ group, although the difference did not achieve statistical significance. Immunochemical staining of cancer tissue revealed significantly higher expression of defensin in the N0 group.Conclusions. Defensin (DEFB4A, DEFB103B, DEFB4B) may be a novel biomarker for early regional metastasis in T1/2 tongue cancer.

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHee Jin Kim
Hee Jin Kim
SKSeong Dong Kim
Seong Dong Kim
YSYeji Shim
Yeji Shim
SLSang Yeon Lee
Sang Yeon Lee
MSMyung-Whun Sung
Myung-Whun Sung
JHJ. Hun Hah
J. Hun Hah
Kim H, et al. J Korean Med Sci. 2016 Aug;31(8):1300-1306. https://doi.org/10.3346/jkms.2016.31.8.1300